Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Infiltrating Bladder Urothelial Carcinoma × transplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Infiltrating Bladder Urothelial Carcinoma 1

Interventions

Gemcitabine 2 Cystectomy 2 Cisplatin 2 transplatin 1 pembrolizumab 1 pegfilgrastim 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Radiation 1 Platinum 1 Chemoradiotherapy 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02944357 2017-11-17

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

Mayo Clinic

Phase NA Withdrawn

Infiltrating Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡